- Home
- ANSC vs PRTA Comparison
ANSC vs PRTA Comparison
Compare ANSC & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANSC | PRTA |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.0M | 482.3M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ANSC | PRTA |
|---|---|---|
| Price | $11.22 | $9.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | 42.4K | ★ 351.6K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $814,000.00 |
| Revenue This Year | N/A | $1,395.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $55.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.57 | $4.32 |
| 52 Week High | $11.24 | $16.16 |
Technical Indicators
Market Signals| Indicator | ANSC | PRTA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.78 |
| Support Level | N/A | $8.91 |
| Resistance Level | N/A | $10.30 |
| Average True Range (ATR) | 0.00 | 0.52 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 74.91 |
Price Performance
Historical ComparisonAbout ANSC Agriculture & Natural Solutions Acquisition Corporation
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.